Last reviewed · How we verify

NCT04382248

The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation

Completed NA Last updated 17 February 2022
What this trial tests

NA trial testing Smartphone App in Medication Compliance in 22 participants. Completed in 30 November 2021.

Timeline
15 October 2020
Primary endpoint
31 August 2021
30 November 2021

Quick facts

Lead sponsorDuke University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment22
Start date15 October 2020
Primary completion31 August 2021
Estimated completion30 November 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Duke University

Who can join

Adults 12 to 40, any sex, with Medication Compliance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the feasibility and acceptability of a mobile app to improve self-management skills and medication adherence in kidney transplantation, to assess the clinical benefit of mobile app in combination with tailored coaching using text messaging to enhance patient activation, self-management and medication adherence and to determine whether immunological biomarkers such as cell-free DNA and donor specific antibodies are associated with self-management and medication adherence.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot Trial.
    Pollock MD, Stauffer N, Lee HJ, Chow SC, et al · · 2023 · cited 7× · PMID 36935874 · DOI 10.1097/txd.0000000000001462

Verify or expand the search:

Other trials of Smartphone App

Trials testing the same drug.

Other recruiting trials for Medication Compliance

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04382248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing